OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Destination Vector pCMV6-Entry2

pCMV6-Entry2, mammalian vector with C-terminal Myc-DDK tag, 10ug

Specifications Custom Cloning Product Manual FAQs
Catalog No. Description Price Availability  
PS100063 pCMV6-Entry2, mammalian vector with C-terminal Myc-DDK tag, 10ug $360 In Stock
TA50011-100 Clone OTI4C5, Anti-DDK monoclonal antibody, 100ul $248 In Stock
Add to Shopping Cart
Features:
  • pCMV6-Entry2 vector is the secondary entry vector for TrueORF clones, This vector is used when the insert is difficult to be cloned into the primary entry vector, pCMV6-Entry.
  • pCMV6-Entry2 vector exhibits the same functional properties of pCMV6-Entry, including kanamycin-resistance in E.coli, Neomycin-resistance in mammalian cells, protein expression driven by CMV. The multiple cloning sites are also identical to pCMV6-Entry.
  • ORFs cloned in this vector will be expressed in mammalian cells as a tagged protein with the C-terminal Myc-DDK tags. (DDK is the same as FLAG® which is a registered trademark of Sigma Aldrich).
  • Such clones are the best for detection and purification of the transgene using anti-Myc or anti-DDK antibodies.
  • Serve as the entry vector in the PrecisionShuttle system to transfer the ORF sequence into any destination vectors for other tagging options or other expression platforms.
pCMV6-Entry2, mammalian vector with C-terminal Myc-DDK tag, 10ug Vector Image
Schematic of the multiple cloning sites:
pCMV6-Entry2, mammalian vector with C-terminal Myc-DDK tag, 10ug MCS Image
Download full vector sequence

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title